MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
3.760
-0.010 (-0.27%)
Nov 4, 2024, 4:00 PM EST - Market closed
MaxCyte Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for MaxCyte stock have an average target of 8.67, with a low estimate of 7.00 and a high estimate of 11. The average target predicts an increase of 130.59% from the current stock price of 3.76.
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 23, 2024.
Analyst Ratings
The average analyst rating for MaxCyte stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +192.55% | Apr 23, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +192.55% | Mar 13, 2024 |
| BTIG | BTIG | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +112.77% | Mar 13, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +86.17% | Nov 29, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $12 | Buy | Reiterates | $12 | +219.15% | Oct 5, 2023 |
Financial Forecast
Revenue This Year
37.66M
from 41.29M
Decreased by -8.79%
Revenue Next Year
46.50M
from 37.66M
Increased by 23.47%
EPS This Year
-0.43
from -0.37
EPS Next Year
-0.41
from -0.43
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 39.2M | 52.3M | 67.1M | ||
| Avg | 37.7M | 46.5M | 60.9M | ||
| Low | 35.3M | 41.3M | 54.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -5.1% | 38.9% | 44.3% | ||
| Avg | -8.8% | 23.5% | 31.0% | ||
| Low | -14.6% | 9.6% | 17.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.42 | -0.33 | -0.43 |
| Avg | -0.43 | -0.41 | -0.42 |
| Low | -0.46 | -0.47 | -0.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.